Evidence map›Paper›PMID 33185753›Full record

ArticleOdontology2021

Peri-implant treatment reduces the salivary levels of Colony stimulator factor-1 and S100A8/A9.

João Martins de Mello-Neto, Mayla Kezy Silva Teixeira, Glaucia Schuindt Teixeira, Eduardo José Veras Lourenço, Daniel Moraes Telles, Ronaldo Lira-Junior, Deepak Ipe, Raj G Nair, Elisabeth Almer Boström, Carlos Marcelo Figueredo

Abstract read
PubMed Publisher
In one paragraph

Article in Odontology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.2field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 3 countries.

João Martins de Mello-NetoSchool of Dentistry and Oral Health and Menzies Health Institute Queensland, Griffith University Queensland, Gold Coast campus Parklands Drive, Southport, QLD, 4222, Australia.
Mayla Kezy Silva TeixeiraDepartment of Prosthodontics, Faculty of Odontology, Rio de Janeiro State University, Rio de Janeiro, Brazil.
Glaucia Schuindt TeixeiraDepartment of Prosthodontics, Faculty of Odontology, Rio de Janeiro State University, Rio de Janeiro, Brazil.
Eduardo José Veras LourençoDepartment of Prosthodontics, Faculty of Odontology, Rio de Janeiro State University, Rio de Janeiro, Brazil.
Daniel Moraes TellesDepartment of Prosthodontics, Faculty of Odontology, Rio de Janeiro State University, Rio de Janeiro, Brazil.
Ronaldo Lira-JuniorDepartment of Dental Medicine, Karolinska Institutet, Stockholm, Sweden.
Deepak IpeSchool of Dentistry and Oral Health and Menzies Health Institute Queensland, Griffith University Queensland, Gold Coast campus Parklands Drive, Southport, QLD, 4222, Australia.
Raj G NairOral Medicine and Oral Oncology, Griffith and Menzies Health Institute Queensland, Southport, QLD, Australia.
Elisabeth Almer BoströmDepartment of Dental Medicine, Karolinska Institutet, Stockholm, Sweden.
Carlos Marcelo FigueredoSchool of Dentistry and Oral Health and Menzies Health Institute Queensland, Griffith University Queensland, Gold Coast campus Parklands Drive, Southport, QLD, 4222, Australia. c.dasilvafigueredo@griffith.edu.au.ORCID http://orcid.org/0000-0003-0222-9231
Griffith University · AUUniversidade do Estado do Rio de Janeiro · BRKarolinska Institutet · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study evaluated the impact of peri-implant treatment in the salivary levels of Colony stimulator factor -1 (CSF-1), S100A8/A9 and S100A12 in patients having mucositis or peri-implantitis. As a secondary aim, we analysed the correlation between the salivary and peri-implant crevicular fluid (PICF) levels. Forty-seven patient, 27 having mucositis (mean age 63.11 ± 7.78) and 20 having peri-implantitis (61.25 ± 7.01) participated in the study. Clinical parameters, probing pocket depth, clinical attachment level, % of plaque and bleeding on probing were evaluated. Unstimulated whole saliva was collected from all patients, while PICF was collected only from a patient's subgroup (n = 20). Samples were collected before and 3 months after peri-implant treatment. Enzyme-linked immunosorbent assays determined levels of CSF-1, S100A8/A9 and S100A12. Clinical parameters improved and salivary levels of CSF-1 and S100A8/A9, but not S100A12, reduced significantly after treatment in both groups. No significant correlation was found in the salivary and PICF levels of the same molecule. In conclusion, the treatment of peri-implant disease significantly improved the clinical parameters and reduced the salivary levels of CSF-1 and S100A8/A9. The salivary expressions of CSF-1, S100A8/A9 and S100A12 did not correlate with their own expression in PICF.

Indexed as

Dental ImplantsPeri-ImplantitisAgedEnzyme-Linked Immunosorbent AssayGingival Crevicular FluidHumansMiddle AgedSalivaDental ImplantsCalprotectinCSF-1Peri-implantitisS100A12 proteinSaliva

Identifiers

PMID33185753
OpenAlexW3101651505

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.